Announcements Trials
Browse Landscape

Phase

Phase NA 63Phase 2 5Phase 1 5Phase 4 3Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 1Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Breast 5Thoracic 3Other hematologic neoplasm 3Genitourinary 3CNS 3Tumor-Agnostic 2Sarcoma 2Plasma cell 2Lymphoid 2Gynecologic 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1Pancreatic Neoplasms 1Colonic Neoplasms 1Ascites 1

Interventions

Oxaliplatin 778Fluorouracil 637Capecitabine 573Gemcitabine 478Leucovorin 458Irinotecan 444Bevacizumab 443Cisplatin 337Radiotherapy 282Cetuximab 251Paclitaxel 180S 1 (combination) 175pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 130apatinib 130130-nm albumin-bound paclitaxel 127Folfox protocol 120durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106Surgical Procedures, Operative 102regorafenib 101Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Blood Specimen Collection × Gastrointestinal × Clear all
NCT06425133 2024-12-24

CARE

Centre Hospitalier Universitaire de Besancon

Phase 2 Recruiting
174 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06046963 2023-09-21

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Zhejiang Cancer Hospital

Phase 2 Unknown
35 enrolled
Gastrointestinal

Ascites, Stomach Neoplasms

NCT04425564 2020-06-11

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

National Cancer Institute, Egypt

Phase 2 Completed
70 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01579357 2015-03-09

Pharmacokinetics and Metabolic Activation of Capecitabine

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01227018 2014-07-23

PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
15 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡